×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Transradial Access Devices Market

ID: MRFR/HC/54386-HCR
200 Pages
Rahul Gotadki
October 2025

US Transradial Access Devices Market Research Report By Product (Catheters, Guidewires), By Application (Drug Administration, Blood Transfusion), By Disease Area (Cardiovascular Disease, Cancer, Strokes), and By End User (Hospitals, Clinics) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Transradial Access Devices Market
 Infographic
Purchase Options

US Transradial Access Devices Market Summary

As per MRFR analysis, the US transradial access-devices market size was estimated at 362.45 USD Million in 2024. The US transradial access-devices market is projected to grow from 389.49 USD Million in 2025 to 800.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.46% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US transradial access-devices market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements in transradial access-devices are enhancing procedural efficiency and patient outcomes.
  • The largest segment in this market is the cardiovascular devices segment, while the fastest-growing segment is anticipated to be the neurovascular devices segment.
  • Regulatory changes are fostering innovation and improving safety standards within the transradial access-devices market.
  • Rising demand for minimally invasive procedures and technological innovations in medical devices are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 362.45 (USD Million)
2035 Market Size 800.0 (USD Million)

Major Players

Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US)

US Transradial Access Devices Market Trends

The transradial access-devices market is currently experiencing notable growth, driven by advancements in medical technology and an increasing preference for minimally invasive procedures. This shift is largely attributed to the benefits associated with transradial access, such as reduced recovery times and lower complication rates compared to traditional methods. As healthcare providers continue to adopt these devices, the market is likely to expand further, reflecting a broader trend towards patient-centered care. Additionally, the rising prevalence of cardiovascular diseases in the US is propelling demand for effective diagnostic and therapeutic solutions, thereby enhancing the market's potential. Moreover, the regulatory landscape is evolving, with agencies emphasizing safety and efficacy in medical devices. This regulatory focus may encourage innovation within the transradial access-devices market, as manufacturers strive to meet stringent standards. Furthermore, educational initiatives aimed at healthcare professionals are likely to increase awareness and proficiency in using these devices, which could further stimulate market growth. As the healthcare sector continues to adapt to changing patient needs and technological advancements, the transradial access-devices market appears poised for sustained development in the coming years.

Technological Advancements

Recent innovations in transradial access-devices are enhancing their functionality and safety. Manufacturers are integrating advanced materials and designs that improve ease of use and patient comfort. These developments may lead to increased adoption rates among healthcare providers.

Regulatory Changes

The evolving regulatory environment is influencing the transradial access-devices market. Stricter guidelines from health authorities are pushing manufacturers to prioritize safety and efficacy, which could result in higher quality products entering the market.

Increased Training and Education

There is a growing emphasis on training healthcare professionals in the use of transradial access-devices. Enhanced educational programs may improve proficiency and confidence among practitioners, potentially leading to greater utilization of these devices in clinical settings.

US Transradial Access Devices Market Drivers

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure in the United States is a key driver for the transradial access-devices market. As hospitals and clinics invest in modern facilities and advanced medical technologies, the availability of transradial access devices is likely to increase. This expansion is supported by government initiatives aimed at improving healthcare access and quality. With more healthcare facilities equipped to perform transradial procedures, the market is expected to witness substantial growth, reflecting the ongoing commitment to enhancing healthcare delivery across the nation.

Technological Innovations in Medical Devices

Technological advancements play a crucial role in shaping the transradial access-devices market. Innovations such as advanced imaging techniques, improved catheter designs, and enhanced safety features are driving the adoption of these devices. For instance, the introduction of next-generation catheters with better maneuverability and flexibility has led to increased procedural success rates. The market for these innovative devices is expected to reach $1.5 billion by 2026, indicating a robust growth trajectory. As healthcare providers seek to improve patient outcomes, the demand for technologically advanced transradial access devices is likely to rise.

Growing Prevalence of Cardiovascular Diseases

The transradial access-devices market is significantly influenced by the rising prevalence of cardiovascular diseases in the United States. With heart disease remaining a leading cause of mortality, the demand for effective diagnostic and interventional procedures is increasing. Data suggests that approximately 697,000 deaths occur annually due to heart disease, prompting healthcare systems to adopt more efficient treatment methods. This trend is likely to drive the growth of the transradial access-devices market, as these devices are essential for performing various cardiovascular interventions, thereby addressing the urgent need for effective healthcare solutions.

Increased Focus on Patient Safety and Comfort

Patient safety and comfort are becoming paramount in healthcare, influencing the transradial access-devices market. The shift towards procedures that minimize patient discomfort and reduce the risk of complications is driving the adoption of transradial access techniques. Studies indicate that transradial access is associated with lower rates of bleeding and vascular complications compared to traditional femoral access. As healthcare providers prioritize patient-centered care, the demand for devices that enhance safety and comfort is expected to grow, further propelling the transradial access-devices market.

Rising Demand for Minimally Invasive Procedures

The transradial access-devices market is experiencing a notable increase in demand due to the growing preference for minimally invasive procedures among healthcare providers and patients. This trend is driven by the advantages associated with transradial access, such as reduced recovery time, lower complication rates, and enhanced patient comfort. According to recent data, minimally invasive procedures are projected to grow at a CAGR of approximately 8% over the next five years. As more healthcare facilities adopt these techniques, the transradial access-devices market is likely to expand, reflecting the shift towards less invasive surgical options.

Market Segment Insights

Transradial Access Devices Market Product Insights

The US Transradial Access Devices Market has gained significant attention due to its robust growth and innovative advancements within the Product segment, primarily focusing on Catheters and Guidewires. This market has evolved as a result of increasing demand for minimally invasive procedures, which are driving the adoption of transradial access methods across various healthcare settings in the United States. Catheters have become indispensable tools in diagnostic and therapeutic procedures, providing enhanced safety and efficiency for patients undergoing cardiac interventions. Their design and functionality contribute to lower complication rates and shorter recovery times, making them a preferred choice among healthcare providers.

Guidewires play a vital role in facilitating access to targeted sites, offering flexibility and precision during complex procedures, particularly in cardiology and radiology. The ongoing advancements in technology have led to the development of sophisticated guidewires that improve maneuverability and reduce vessel trauma, thereby enhancing the overall patient experience. With the American College of Cardiology and other organizations advocating for the adoption of transradial access techniques over traditional femoral methods, the emphasis on training healthcare professionals in the use of Catheters and Guidewires has also increased.

Furthermore, the growing geriatric population and rising prevalence of cardiovascular diseases are contributing to the elevated demand for effective access devices. Regulatory bodies in the US have established guidelines promoting the use of transradial access due to its numerous advantages, fueling market growth. The emphasis on procedural efficiency and patient safety is fostering investments in Research and Development, leading to innovations in Catheters and Guidewires. This scenario encourages manufacturers to focus on enhancing the quality and performance of Transradial Access Devices, which has the potential to expand their market reach significantly in the coming years.

The integration of digital technologies, such as real-time imaging and monitoring systems, is poised to further streamline procedures, improve outcomes, and elevate the overall standard of care within the US healthcare system.

Overall, the Product segment within the US Transradial Access Devices Market reflects a significant shift toward advanced, patient-centric solutions as healthcare providers strive to improve procedural effectiveness and minimize risks associated with access challenges. The continuous evolution and refinement of Catheters and Guidewires underscore their importance in treating an array of conditions while aligning with the broader goals of promoting safe, precise, and cost-effective healthcare practices in the United States.

Transradial Access Devices Market Application Insights

The US Transradial Access Devices Market exhibits significant growth in the Application segment, featuring areas such as Drug Administration and Blood Transfusion. Drug Administration plays a critical role in enhancing patient comfort and reducing infection risks, as transradial access is increasingly favored for its minimal complications compared to traditional approaches. Meanwhile, Blood Transfusion is a vital application, as it ensures the effective delivery of blood products to patients in need, and transradial techniques streamline this process, increasing efficiency in emergency and clinical settings.

Both applications are witnessing advancements driven by increased procedural safety and growing adoption rates among healthcare providers. Furthermore, the US healthcare landscape emphasizes boosting patient outcomes alongside cost efficiency, which positions these applications as essential components. As hospitals and clinics continue to prioritize transradial approaches, the focus on innovation within these applications will likely present considerable opportunities within the US Transradial Access Devices Market. The steady growth and development of such applications are indicative of their critical role in ensuring effective patient care and satisfaction.

Transradial Access Devices Market Disease Area Insights

The US Transradial Access Devices Market encompasses various disease areas, notably Cardiovascular Disease, Cancer, and Strokes, each showing significant relevance to healthcare delivery in the region. Cardiovascular Disease remains a leading cause of mortality in the United States, driving the demand for innovative transradial access solutions that offer improved procedural outcomes and reduced complications. Cancer treatment often involves complex interventions where transradial access can enhance safety and recovery times, positioning it as a critical advancement in oncological practices.

Similarly, the management and treatment of Strokes highlight the need for rapid and effective access techniques, making transradial devices a crucial component in emergent care settings. Together, these disease areas contribute to the ongoing evolution of the US Transradial Access Devices Market, influenced by factors such as aging demographics and advancements in medical technologies. The segmentation reflects the growing focus on minimally invasive techniques, aiming to improve patient comfort and procedural efficacy across various medical disciplines.

With the increasing prevalence of these diseases, the demand for transradial access devices is poised to escalate, marking significant opportunities for growth and innovation within the industry.

Transradial Access Devices Market End User Insights

The End User segment of the US Transradial Access Devices Market is primarily comprised of Hospitals and Clinics, where the demand for these devices is significantly driven by the increasing preference for minimally invasive procedures. Hospitals play a crucial role in the utilization of Transradial Access Devices, as they often implement advanced technologies to enhance patient outcomes and reduce recovery times. The rise in cardiovascular diseases has further accentuated the need for efficient access devices within these facilities.

Clinics, on the other hand, contribute to market growth by providing accessible outpatient treatments and procedures that leverage transradial approaches, enhancing patient convenience and safety.

This segment's importance is underscored by the consistent focus on improving healthcare delivery in the US, supported by investments in technology and a shift towards outpatient care models. Consequently, both Hospitals and Clinics are significant players in shaping the landscape of the US Transradial Access Devices Market, fostering a trend towards increased adoption and integration of advanced devices in routine practice. The emphasis on patient-centered care and improved procedural efficiency continues to drive the relevance of this segment in the broader market context.

Get more detailed insights about US Transradial Access Devices Market

Key Players and Competitive Insights

The transradial access-devices market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Boston Scientific Corporation (US), Medtronic plc (IE), and Abbott Laboratories (US) are actively pursuing strategies that emphasize technological advancements and market expansion. Boston Scientific Corporation (US) has focused on enhancing its product portfolio through innovative designs that improve patient outcomes, while Medtronic plc (IE) is leveraging its extensive research capabilities to develop next-generation access devices. Abbott Laboratories (US) appears to be concentrating on strategic collaborations to enhance its market presence, indicating a trend towards cooperative growth among leading firms. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and collaboration are paramount.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in the context of the transradial access-devices market, which is moderately fragmented, with several players vying for market share. The collective influence of key players is significant, as their operational strategies often set benchmarks for industry standards and practices, thereby shaping the overall market structure.

In October 2025, Boston Scientific Corporation (US) announced the launch of a new transradial access device designed to enhance procedural efficiency and patient comfort. This strategic move is likely to reinforce the company's position as a leader in the market, as it addresses the growing demand for minimally invasive procedures. The introduction of this device not only showcases Boston Scientific's commitment to innovation but also reflects a broader trend towards patient-centric solutions in the healthcare sector.

In September 2025, Medtronic plc (IE) entered into a partnership with a leading technology firm to integrate artificial intelligence into its transradial access devices. This collaboration is expected to enhance the precision and safety of procedures, potentially setting a new standard in the industry. By embracing AI, Medtronic is positioning itself at the forefront of technological advancement, which may provide a competitive edge in an increasingly tech-driven market.

In August 2025, Abbott Laboratories (US) expanded its distribution network for transradial access devices across North America, aiming to improve accessibility for healthcare providers. This strategic expansion is indicative of Abbott's focus on enhancing its market reach and ensuring that its innovative products are readily available to a broader audience. Such moves are essential in a market where accessibility can significantly influence competitive positioning.

As of November 2025, the transradial access-devices market is witnessing trends that emphasize digitalization, sustainability, and the integration of advanced technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing product offerings. Looking ahead, it is anticipated that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking in maintaining a competitive edge in the evolving market.

Key Companies in the US Transradial Access Devices Market market include

Industry Developments

The US Transradial Access Devices Market has seen significant developments recently, particularly with advancements in technology and product offerings. Companies such as Medtronic and Abbott Laboratories are continually enhancing their transradial access devices with innovations aimed at improving patient outcomes and procedural efficiency. In terms of market growth, the demand for minimally invasive procedures has propelled the valuation of this market segment, with projections indicating a substantial increase in surgical applications. Current affairs also spotlight the collaborative efforts among key players, including Endologix and Terumo, to expand their market reach and product capabilities.

Notably, there have been recent mergers and acquisitions; for instance, in September 2023, Johnson and Johnson announced the acquisition of a digital health platform to enhance its cardiovascular portfolio. Additionally, Boston Scientific has committed to significant investments in Research and Development aimed at new transradial devices. Overall, the focus on safety, efficacy, and patient-centered care continues to drive the trends in the US Transradial Access Devices Market, reflecting the increasing importance of these devices in clinical practice over the past few years.

Future Outlook

US Transradial Access Devices Market Future Outlook

The Transradial Access Devices Market is projected to grow at a 7.46% CAGR from 2024 to 2035, driven by technological advancements and increasing procedural adoption.

New opportunities lie in:

  • Development of advanced hemostatic devices for improved patient outcomes.
  • Expansion into outpatient settings with portable access devices.
  • Strategic partnerships with hospitals for integrated access solutions.

By 2035, the market is expected to achieve substantial growth and innovation.

Market Segmentation

US Transradial Access Devices Market Product Outlook

  • Catheters
  • Guidewires

US Transradial Access Devices Market End User Outlook

  • Hospitals
  • Clinics

US Transradial Access Devices Market Application Outlook

  • Drug Administration
  • Blood Transfusion

US Transradial Access Devices Market Disease Area Outlook

  • Cardiovascular Disease
  • Cancer
  • Strokes

Report Scope

MARKET SIZE 2024 362.45(USD Million)
MARKET SIZE 2025 389.49(USD Million)
MARKET SIZE 2035 800.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.46% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US)
Segments Covered Product, Application, Disease Area, End User
Key Market Opportunities Advancements in minimally invasive techniques enhance growth potential in the transradial access-devices market.
Key Market Dynamics Technological advancements and regulatory changes drive growth in the transradial access-devices market.
Countries Covered US

Leave a Comment

FAQs

What is the projected market size of the US Transradial Access Devices Market in 2024?

The US Transradial Access Devices Market is expected to be valued at 450.0 million USD in 2024.

What will the market size of the US Transradial Access Devices Market be by 2035?

By 2035, the market is projected to reach a value of 1050.0 million USD.

What is the expected CAGR for the US Transradial Access Devices Market from 2025 to 2035?

The expected CAGR for the market during this period is 8.007%.

What is the market size for Catheters in the US Transradial Access Devices Market in 2024?

The market size for Catheters is anticipated to be valued at 250.0 million USD in 2024.

What is the market size for Guidewires in the US Transradial Access Devices Market in 2024?

The Guidewires market is expected to be valued at 200.0 million USD in 2024.

Who are the major players in the US Transradial Access Devices Market?

Key players include Endologix, Svelte Medical Systems, Medtronic, Abbott Laboratories, and Boston Scientific.

What is the expected market size for Catheters by 2035?

The market for Catheters is projected to grow to 570.0 million USD by 2035.

What will be the market size for Guidewires by 2035?

The Guidewires market is predicted to reach a value of 480.0 million USD by 2035.

What are some key growth drivers for the US Transradial Access Devices Market?

Key growth drivers include advancements in minimally invasive procedures and increasing preference for transradial access.

What impact do current trends have on the US Transradial Access Devices Market?

Emerging trends indicate robust growth opportunities driven by innovation and the expansion of interventional cardiology procedures.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions